Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
November 1, 1995
HLA associations in the antitumor response against malignant melanoma
F M Marincola, P Shamamian, L Rivoltini, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1998
Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing
L Rivoltini, M Radrizzani, P Accornero, et al.
Melanoma Research
|
October 24, 2002
Cytotoxic T-lymphocyte responses in melanoma through in vitro stimulation with the Melan-A peptide analogue A27L: a qualitative analysis
B Palermo, R Campanelli, S Garbelli, et al.
Critical Reviews in Immunology
|
January 7, 1998
Recognition of melanoma-derived antigens by CTL: possible mechanisms involved in down-regulating anti-tumor T-cell reactivity
L Rivoltini, D J Loftus, P Squarcina, et al.
Targeted Oncology
|
September 19, 2014
Dose-finding/phase II trial: bevacizumab, immunotherapy, and chemotherapy (BIC) in metastatic renal cell cancer (mRCC). Antitumor effects and variations of circulating T regulatory cells (Treg)
M Donini, S Buti, S Lazzarelli, et al.
Cell Death & Disease
|
March 4, 2011
Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells
M L Marino, S Fais, M Djavaheri-Mergny, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
May 1, 1996
Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions
F M Marincola, Y M Hijazi, P Fetsch, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 23, 1997
Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells
B J Czerniecki, C Carter, L Rivoltini, et al.
British Journal of Cancer
|
August 8, 2014
Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy
M Tazzari, T Negri, F Rini, et al.
Human Gene Therapy
|
December 28, 1999
Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells
F Arienti, F Belli, F Napolitano, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
November 1, 1995
HLA associations in the antitumor response against malignant melanoma
F M Marincola, P Shamamian, L Rivoltini, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1998
Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing
L Rivoltini, M Radrizzani, P Accornero, et al.
Melanoma Research
|
October 24, 2002
Cytotoxic T-lymphocyte responses in melanoma through in vitro stimulation with the Melan-A peptide analogue A27L: a qualitative analysis
B Palermo, R Campanelli, S Garbelli, et al.
Critical Reviews in Immunology
|
January 7, 1998
Recognition of melanoma-derived antigens by CTL: possible mechanisms involved in down-regulating anti-tumor T-cell reactivity
L Rivoltini, D J Loftus, P Squarcina, et al.
Targeted Oncology
|
September 19, 2014
Dose-finding/phase II trial: bevacizumab, immunotherapy, and chemotherapy (BIC) in metastatic renal cell cancer (mRCC). Antitumor effects and variations of circulating T regulatory cells (Treg)
M Donini, S Buti, S Lazzarelli, et al.
Cell Death & Disease
|
March 4, 2011
Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells
M L Marino, S Fais, M Djavaheri-Mergny, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
May 1, 1996
Analysis of expression of the melanoma-associated antigens MART-1 and gp100 in metastatic melanoma cell lines and in in situ lesions
F M Marincola, Y M Hijazi, P Fetsch, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 23, 1997
Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells
B J Czerniecki, C Carter, L Rivoltini, et al.
British Journal of Cancer
|
August 8, 2014
Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy
M Tazzari, T Negri, F Rini, et al.
Human Gene Therapy
|
December 28, 1999
Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells
F Arienti, F Belli, F Napolitano, et al.
Page
of 9